Harpoon Therapeutics offers an example of biotech’s volatility. The stock advanced as much as 191% intraday Monday before settling down to a gain of 22.61%.
Harpoon Therapeutics offers an example of biotech’s volatility. The stock advanced as much as 191% intraday Monday before settling down to a gain of 22.61%.